about
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision End...
Read More
35.91
4.25
(13.42%)
666.8K
XNAS Volume
XNAS 12 Jan, 2026 12:30 PM (EST)
Board Meeting
The next board meeting for MBX Biosciences Inc is on 13 Jan 2026 for the purpose of 44(th) Annual J.P. Morgan Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
MBX Biosciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..